News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
948 Results
Type
Article (56)
Press Release (892)
Section
Business (269)
Deals (81)
Drug Development (128)
FDA (31)
Job Trends (13)
News (501)
Policy (31)
Tag
Alliances (50)
Approvals (29)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (11)
Bladder cancer (7)
Cancer (26)
Clinical research (129)
Collaboration (2)
Compensation (2)
C-suite (1)
Data (15)
Diagnostics (6)
Earnings (129)
Events (174)
Executive appointments (1)
FDA (38)
Government (3)
Guidances (1)
Healthcare (16)
Immunology and inflammation (1)
Indications (1)
Infectious disease (2)
IPO (50)
Job creations (2)
Legal (1)
Lung cancer (1)
Medical device (8)
Medtech (8)
Mergers & acquisitions (31)
NextGen: Class of 2025 (7)
Non-profit (2)
Patents (1)
People (88)
Phase I (14)
Phase II (44)
Phase III (69)
Pipeline (1)
Policy (1)
Postmarket research (10)
Preclinical (6)
Prostate cancer (8)
Radiopharmaceuticals (1)
Rare diseases (1)
Regulatory (35)
RSV (1)
Startups (4)
Vaccines (2)
Date
Last 7 days (5)
Last 30 days (17)
Last 365 days (77)
2025 (46)
2024 (70)
2023 (58)
2022 (69)
2021 (76)
2020 (110)
2019 (81)
2018 (54)
2017 (42)
2016 (26)
2015 (56)
2014 (54)
2013 (23)
2012 (34)
2011 (30)
2010 (44)
Location
Asia (51)
Australia (6)
California (5)
Europe (129)
Florida (3)
Japan (2)
Massachusetts (4)
New Jersey (44)
New York (3)
Northern California (4)
Ohio (4)
Pennsylvania (3)
Southern California (1)
United States (69)
Utah (3)
948 Results for "urogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bladder cancer
UroGen’s Bladder Cancer Drug Wins FDA Approval Over Adcomm’s Objections
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely randomized study to back up the application.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
June 13, 2025
·
11 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025
June 9, 2025
·
2 min read
Press Releases
UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA
May 27, 2025
·
1 min read
Press Releases
UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update
May 12, 2025
·
19 min read
Press Releases
UroGen Pharma to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
May 1, 2025
·
1 min read
Press Releases
UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Designed to Study Real-World Use of JELMYTO in Low-Grade Upper Tract Urothelial Cancer
June 2, 2025
·
9 min read
Press Releases
UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
June 2, 2025
·
7 min read
Press Releases
UroGen Announces FDA Advisory Committee for UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
May 7, 2025
·
6 min read
Press Releases
UroGen Pharma to Present at Upcoming Investor Conferences
January 30, 2025
·
1 min read
1 of 95
Next
